UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Liberty Media Series A
FWONA
$23.6B
| $660K | ﹤0.01% |
10,268
-989
| -9% | -$62.9K |
|
|
EFXT
2502
Enerflex
EFXT
$2.44B
| $659K | ﹤0.01% |
+122,114
| New | +$663K |
|
2503
FuboTV Inc
FUBO
$273M
| $646K | ﹤0.01% |
43,411
+22,361
| +106% | +$358K |
|
|
GATO
2504
DELISTED
Gatos Silver, Inc.
GATO
| $642K | ﹤0.01% |
+61,476
| New | +$650K |
|
2505
Weave Communications
WEAV
$423M
| $638K | ﹤0.01% |
70,679
+51,679
| +272% | +$503K |
|
2506
Bristow Group
VTOL
$1.36B
| $636K | ﹤0.01% |
18,956
+8,235
| +77% | +$255K |
|
2507
Ginkgo Bioworks
DNA
$521M
| $635K | ﹤0.01% |
47,540
+11,729
| +33% | +$350K |
|
2508
Tejon Ranch
TRC
$451M
| $633K | ﹤0.01% |
37,130
+25,937
| +232% | +$431K |
|
2509
Kenon Holdings
KEN
$3.45B
| $633K | ﹤0.01% |
+25,779
| New | +$611K |
|
|
CRON
2510
Cronos Group
CRON
$1.14B
| $632K | ﹤0.01% |
+271,176
| New | +$699K |
|
2511
Immunome
IMNM
$2.83B
| $630K | ﹤0.01% |
52,054
+40,354
| +345% | +$631K |
|
2512
Lindblad Expeditions
LIND
$2.22B
| $625K | ﹤0.01% |
64,742
+25,306
| +64% | +$196K |
|
2513
National Presto Industries
NPK
$989M
| $624K | ﹤0.01% |
8,309
+5,857
| +239% | +$461K |
|
2514
Titan Machinery
TITN
$445M
| $624K | ﹤0.01% |
39,232
+24,072
| +159% | +$503K |
|
2515
Lufax Holding
LU
$1.3B
| $624K | ﹤0.01% |
263,125
+179,002
| +213% | +$683K |
|
2516
Allogene Therapeutics
ALLO
$694M
| $622K | ﹤0.01% |
266,784
+96,497
| +57% | +$285K |
|
|
CVGW
2517
DELISTED
Calavo Growers
CVGW
| $619K | ﹤0.01% |
27,273
+7,514
| +38% | +$197K |
|
2518
Fate Therapeutics
FATE
$326M
| $618K | ﹤0.01% |
+188,460
| New | +$825K |
|
2519
NextNav
NN
$2.23B
| $617K | ﹤0.01% |
76,103
+42,672
| +128% | +$337K |
|
2520
Equity Bancshares
EQBK
$1.05B
| $616K | ﹤0.01% |
+17,492
| New | +$586K |
|
|
ATSG
2521
DELISTED
Air Transport Services Group
ATSG
| $614K | ﹤0.01% |
44,272
+19,746
| +81% | +$262K |
|
|
EWCZ
2522
DELISTED
European Wax Center
EWCZ
| $614K | ﹤0.01% |
61,801
+36,972
| +149% | +$420K |
|
2523
Kaspi.kz JSC
KSPI
$17.2B
| $613K | ﹤0.01% |
4,750
-11,706
| -71% | -$1.43M |
|
|
RBCP
2524
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $611K | ﹤0.01% |
+5,000
| New | +$609K |
|
|
RVNC
2525
DELISTED
Revance Therapeutics, Inc.
RVNC
| $611K | ﹤0.01% |
237,790
+118,429
| +99% | +$404K |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.